-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
MBX Biosciences, Inc. quarterly Operating Income (Loss) history and growth rate from Q3 2023 to Q3 2024.
- MBX Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$19.6M, a 79.2% decline year-over-year.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)